Global New Chemical Entities (NCE) CDMO Market Growth (Status and Outlook) 2026-2032
The global New Chemical Entities (NCE) CDMO market size is predicted to grow from US$ 3172 million in 2025 to US$ 6817 million in 2032; it is expected to grow at a CAGR of 11.8% from 2026 to 2032.
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.
United States market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key New Chemical Entities (NCE) CDMO players cover KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?New Chemical Entities (NCE) CDMO Industry Forecast? looks at past sales and reviews total world New Chemical Entities (NCE) CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected New Chemical Entities (NCE) CDMO sales for 2026 through 2032. With New Chemical Entities (NCE) CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Chemical Entities (NCE) CDMO industry.
This Insight Report provides a comprehensive analysis of the global New Chemical Entities (NCE) CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on New Chemical Entities (NCE) CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global New Chemical Entities (NCE) CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Chemical Entities (NCE) CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Chemical Entities (NCE) CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of New Chemical Entities (NCE) CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
New Chemical Entities (NCE) refer to new compounds that have not yet been approved for any therapeutic use during the drug development process. These compounds are usually obtained through the synthesis or discovery of new molecules and have new activities or therapeutic potential. NCE is usually the first step in drug development, and after evaluating its safety and effectiveness in clinical trials, it may be applied for marketing. CDMO (Contract Development and Manufacturing Organization) refers to a company that provides drug development and production services, usually working with pharmaceutical companies to help them develop and manufacture NCE. CDMO can provide a range of services from preliminary compound synthesis, process development, to the production of drugs for clinical trials and commercial production. In short, NCE is a newly developed drug ingredient, and CDMO is a service provider that specializes in helping pharmaceutical companies develop and produce NCE.
United States market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for New Chemical Entities (NCE) CDMO is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key New Chemical Entities (NCE) CDMO players cover KATSURA CHEMICAL CO., LTD, Regis Custom API, Neuland Laboratories Ltd., Aspen API, Sai Life Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?New Chemical Entities (NCE) CDMO Industry Forecast? looks at past sales and reviews total world New Chemical Entities (NCE) CDMO sales in 2025, providing a comprehensive analysis by region and market sector of projected New Chemical Entities (NCE) CDMO sales for 2026 through 2032. With New Chemical Entities (NCE) CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world New Chemical Entities (NCE) CDMO industry.
This Insight Report provides a comprehensive analysis of the global New Chemical Entities (NCE) CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on New Chemical Entities (NCE) CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global New Chemical Entities (NCE) CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for New Chemical Entities (NCE) CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global New Chemical Entities (NCE) CDMO.
This report presents a comprehensive overview, market shares, and growth opportunities of New Chemical Entities (NCE) CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Peptide NCE
- Oligonucleotide NCE
- Other
- Tumors
- Cardiovascular Diseases
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KATSURA CHEMICAL CO., LTD
- Regis Custom API
- Neuland Laboratories Ltd.
- Aspen API
- Sai Life Sciences
- Fermion
- Dipharma Francis Srl (Dipharma)
- Cohance
- Suven Pharma
- Syngene
- Aarti Pharmalabs Limited (APL)
- Cerbios-Pharma SA
- PharmaBlock Sciences Nanjing Inc
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Chemical Entities (NCE) CDMO Market Size (2021-2032)
2.1.2 New Chemical Entities (NCE) CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for New Chemical Entities (NCE) CDMO by Country/Region (2021, 2025 & 2032)
2.2 New Chemical Entities (NCE) CDMO Segment by Type
2.2.1 Peptide NCE
2.2.2 Oligonucleotide NCE
2.2.3 Other
2.2.4 New Chemical Entities (NCE) CDMO Market Size by Type
2.2.4.1 New Chemical Entities (NCE) CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
2.3 New Chemical Entities (NCE) CDMO Segment by Application
2.3.1 Tumors
2.3.2 Cardiovascular Diseases
2.3.3 Other
2.3.4 New Chemical Entities (NCE) CDMO Market Size by Application
2.3.4.1 New Chemical Entities (NCE) CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
3 NEW CHEMICAL ENTITIES (NCE) CDMO MARKET SIZE BY PLAYER
3.1 New Chemical Entities (NCE) CDMO Market Size Market Share by Player
3.1.1 Global New Chemical Entities (NCE) CDMO Revenue by Player (2021-2026)
3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player (2021-2026)
3.2 Global New Chemical Entities (NCE) CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW CHEMICAL ENTITIES (NCE) CDMO BY REGION
4.1 New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026)
4.2 Global New Chemical Entities (NCE) CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.4 APAC New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.5 Europe New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026)
5.2 Americas New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
5.3 Americas New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026)
6.2 APAC New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
6.3 APAC New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026)
7.2 Europe New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Chemical Entities (NCE) CDMO by Region (2021-2026)
8.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW CHEMICAL ENTITIES (NCE) CDMO MARKET FORECAST
10.1 Global New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.1.1 Global New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.1.2 Americas New Chemical Entities (NCE) CDMO Forecast
10.1.3 APAC New Chemical Entities (NCE) CDMO Forecast
10.1.4 Europe New Chemical Entities (NCE) CDMO Forecast
10.1.5 Middle East & Africa New Chemical Entities (NCE) CDMO Forecast
10.2 Americas New Chemical Entities (NCE) CDMO Forecast by Country (2027-2032)
10.2.1 United States Market New Chemical Entities (NCE) CDMO Forecast
10.2.2 Canada Market New Chemical Entities (NCE) CDMO Forecast
10.2.3 Mexico Market New Chemical Entities (NCE) CDMO Forecast
10.2.4 Brazil Market New Chemical Entities (NCE) CDMO Forecast
10.3 APAC New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.3.1 China New Chemical Entities (NCE) CDMO Market Forecast
10.3.2 Japan Market New Chemical Entities (NCE) CDMO Forecast
10.3.3 Korea Market New Chemical Entities (NCE) CDMO Forecast
10.3.4 Southeast Asia Market New Chemical Entities (NCE) CDMO Forecast
10.3.5 India Market New Chemical Entities (NCE) CDMO Forecast
10.3.6 Australia Market New Chemical Entities (NCE) CDMO Forecast
10.4 Europe New Chemical Entities (NCE) CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market New Chemical Entities (NCE) CDMO Forecast
10.4.2 France Market New Chemical Entities (NCE) CDMO Forecast
10.4.3 UK Market New Chemical Entities (NCE) CDMO Forecast
10.4.4 Italy Market New Chemical Entities (NCE) CDMO Forecast
10.4.5 Russia Market New Chemical Entities (NCE) CDMO Forecast
10.5 Middle East & Africa New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market New Chemical Entities (NCE) CDMO Forecast
10.5.2 South Africa Market New Chemical Entities (NCE) CDMO Forecast
10.5.3 Israel Market New Chemical Entities (NCE) CDMO Forecast
10.5.4 Turkey Market New Chemical Entities (NCE) CDMO Forecast
10.6 Global New Chemical Entities (NCE) CDMO Forecast by Type (2027-2032)
10.7 Global New Chemical Entities (NCE) CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market New Chemical Entities (NCE) CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Information
11.1.2 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product Offered
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 KATSURA CHEMICAL CO., LTD Main Business Overview
11.1.5 KATSURA CHEMICAL CO., LTD Latest Developments
11.2 Regis Custom API
11.2.1 Regis Custom API Company Information
11.2.2 Regis Custom API New Chemical Entities (NCE) CDMO Product Offered
11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Regis Custom API Main Business Overview
11.2.5 Regis Custom API Latest Developments
11.3 Neuland Laboratories Ltd.
11.3.1 Neuland Laboratories Ltd. Company Information
11.3.2 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product Offered
11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Neuland Laboratories Ltd. Main Business Overview
11.3.5 Neuland Laboratories Ltd. Latest Developments
11.4 Aspen API
11.4.1 Aspen API Company Information
11.4.2 Aspen API New Chemical Entities (NCE) CDMO Product Offered
11.4.3 Aspen API New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aspen API Main Business Overview
11.4.5 Aspen API Latest Developments
11.5 Sai Life Sciences
11.5.1 Sai Life Sciences Company Information
11.5.2 Sai Life Sciences New Chemical Entities (NCE) CDMO Product Offered
11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sai Life Sciences Main Business Overview
11.5.5 Sai Life Sciences Latest Developments
11.6 Fermion
11.6.1 Fermion Company Information
11.6.2 Fermion New Chemical Entities (NCE) CDMO Product Offered
11.6.3 Fermion New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fermion Main Business Overview
11.6.5 Fermion Latest Developments
11.7 Dipharma Francis Srl (Dipharma)
11.7.1 Dipharma Francis Srl (Dipharma) Company Information
11.7.2 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product Offered
11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Dipharma Francis Srl (Dipharma) Main Business Overview
11.7.5 Dipharma Francis Srl (Dipharma) Latest Developments
11.8 Cohance
11.8.1 Cohance Company Information
11.8.2 Cohance New Chemical Entities (NCE) CDMO Product Offered
11.8.3 Cohance New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cohance Main Business Overview
11.8.5 Cohance Latest Developments
11.9 Suven Pharma
11.9.1 Suven Pharma Company Information
11.9.2 Suven Pharma New Chemical Entities (NCE) CDMO Product Offered
11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Suven Pharma Main Business Overview
11.9.5 Suven Pharma Latest Developments
11.10 Syngene
11.10.1 Syngene Company Information
11.10.2 Syngene New Chemical Entities (NCE) CDMO Product Offered
11.10.3 Syngene New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Syngene Main Business Overview
11.10.5 Syngene Latest Developments
11.11 Aarti Pharmalabs Limited (APL)
11.11.1 Aarti Pharmalabs Limited (APL) Company Information
11.11.2 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product Offered
11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Aarti Pharmalabs Limited (APL) Main Business Overview
11.11.5 Aarti Pharmalabs Limited (APL) Latest Developments
11.12 Cerbios-Pharma SA
11.12.1 Cerbios-Pharma SA Company Information
11.12.2 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product Offered
11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cerbios-Pharma SA Main Business Overview
11.12.5 Cerbios-Pharma SA Latest Developments
11.13 PharmaBlock Sciences Nanjing Inc
11.13.1 PharmaBlock Sciences Nanjing Inc Company Information
11.13.2 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product Offered
11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 PharmaBlock Sciences Nanjing Inc Main Business Overview
11.13.5 PharmaBlock Sciences Nanjing Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global New Chemical Entities (NCE) CDMO Market Size (2021-2032)
2.1.2 New Chemical Entities (NCE) CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for New Chemical Entities (NCE) CDMO by Country/Region (2021, 2025 & 2032)
2.2 New Chemical Entities (NCE) CDMO Segment by Type
2.2.1 Peptide NCE
2.2.2 Oligonucleotide NCE
2.2.3 Other
2.2.4 New Chemical Entities (NCE) CDMO Market Size by Type
2.2.4.1 New Chemical Entities (NCE) CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.4.2 Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
2.3 New Chemical Entities (NCE) CDMO Segment by Application
2.3.1 Tumors
2.3.2 Cardiovascular Diseases
2.3.3 Other
2.3.4 New Chemical Entities (NCE) CDMO Market Size by Application
2.3.4.1 New Chemical Entities (NCE) CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
3 NEW CHEMICAL ENTITIES (NCE) CDMO MARKET SIZE BY PLAYER
3.1 New Chemical Entities (NCE) CDMO Market Size Market Share by Player
3.1.1 Global New Chemical Entities (NCE) CDMO Revenue by Player (2021-2026)
3.1.2 Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player (2021-2026)
3.2 Global New Chemical Entities (NCE) CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NEW CHEMICAL ENTITIES (NCE) CDMO BY REGION
4.1 New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026)
4.2 Global New Chemical Entities (NCE) CDMO Annual Revenue by Country/Region (2021-2026)
4.3 Americas New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.4 APAC New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.5 Europe New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
4.6 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026)
5.2 Americas New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
5.3 Americas New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026)
6.2 APAC New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
6.3 APAC New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026)
7.2 Europe New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
7.3 Europe New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa New Chemical Entities (NCE) CDMO by Region (2021-2026)
8.2 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026)
8.3 Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NEW CHEMICAL ENTITIES (NCE) CDMO MARKET FORECAST
10.1 Global New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.1.1 Global New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.1.2 Americas New Chemical Entities (NCE) CDMO Forecast
10.1.3 APAC New Chemical Entities (NCE) CDMO Forecast
10.1.4 Europe New Chemical Entities (NCE) CDMO Forecast
10.1.5 Middle East & Africa New Chemical Entities (NCE) CDMO Forecast
10.2 Americas New Chemical Entities (NCE) CDMO Forecast by Country (2027-2032)
10.2.1 United States Market New Chemical Entities (NCE) CDMO Forecast
10.2.2 Canada Market New Chemical Entities (NCE) CDMO Forecast
10.2.3 Mexico Market New Chemical Entities (NCE) CDMO Forecast
10.2.4 Brazil Market New Chemical Entities (NCE) CDMO Forecast
10.3 APAC New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.3.1 China New Chemical Entities (NCE) CDMO Market Forecast
10.3.2 Japan Market New Chemical Entities (NCE) CDMO Forecast
10.3.3 Korea Market New Chemical Entities (NCE) CDMO Forecast
10.3.4 Southeast Asia Market New Chemical Entities (NCE) CDMO Forecast
10.3.5 India Market New Chemical Entities (NCE) CDMO Forecast
10.3.6 Australia Market New Chemical Entities (NCE) CDMO Forecast
10.4 Europe New Chemical Entities (NCE) CDMO Forecast by Country (2027-2032)
10.4.1 Germany Market New Chemical Entities (NCE) CDMO Forecast
10.4.2 France Market New Chemical Entities (NCE) CDMO Forecast
10.4.3 UK Market New Chemical Entities (NCE) CDMO Forecast
10.4.4 Italy Market New Chemical Entities (NCE) CDMO Forecast
10.4.5 Russia Market New Chemical Entities (NCE) CDMO Forecast
10.5 Middle East & Africa New Chemical Entities (NCE) CDMO Forecast by Region (2027-2032)
10.5.1 Egypt Market New Chemical Entities (NCE) CDMO Forecast
10.5.2 South Africa Market New Chemical Entities (NCE) CDMO Forecast
10.5.3 Israel Market New Chemical Entities (NCE) CDMO Forecast
10.5.4 Turkey Market New Chemical Entities (NCE) CDMO Forecast
10.6 Global New Chemical Entities (NCE) CDMO Forecast by Type (2027-2032)
10.7 Global New Chemical Entities (NCE) CDMO Forecast by Application (2027-2032)
10.7.1 GCC Countries Market New Chemical Entities (NCE) CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 KATSURA CHEMICAL CO., LTD
11.1.1 KATSURA CHEMICAL CO., LTD Company Information
11.1.2 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product Offered
11.1.3 KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 KATSURA CHEMICAL CO., LTD Main Business Overview
11.1.5 KATSURA CHEMICAL CO., LTD Latest Developments
11.2 Regis Custom API
11.2.1 Regis Custom API Company Information
11.2.2 Regis Custom API New Chemical Entities (NCE) CDMO Product Offered
11.2.3 Regis Custom API New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Regis Custom API Main Business Overview
11.2.5 Regis Custom API Latest Developments
11.3 Neuland Laboratories Ltd.
11.3.1 Neuland Laboratories Ltd. Company Information
11.3.2 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product Offered
11.3.3 Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Neuland Laboratories Ltd. Main Business Overview
11.3.5 Neuland Laboratories Ltd. Latest Developments
11.4 Aspen API
11.4.1 Aspen API Company Information
11.4.2 Aspen API New Chemical Entities (NCE) CDMO Product Offered
11.4.3 Aspen API New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Aspen API Main Business Overview
11.4.5 Aspen API Latest Developments
11.5 Sai Life Sciences
11.5.1 Sai Life Sciences Company Information
11.5.2 Sai Life Sciences New Chemical Entities (NCE) CDMO Product Offered
11.5.3 Sai Life Sciences New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Sai Life Sciences Main Business Overview
11.5.5 Sai Life Sciences Latest Developments
11.6 Fermion
11.6.1 Fermion Company Information
11.6.2 Fermion New Chemical Entities (NCE) CDMO Product Offered
11.6.3 Fermion New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Fermion Main Business Overview
11.6.5 Fermion Latest Developments
11.7 Dipharma Francis Srl (Dipharma)
11.7.1 Dipharma Francis Srl (Dipharma) Company Information
11.7.2 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product Offered
11.7.3 Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Dipharma Francis Srl (Dipharma) Main Business Overview
11.7.5 Dipharma Francis Srl (Dipharma) Latest Developments
11.8 Cohance
11.8.1 Cohance Company Information
11.8.2 Cohance New Chemical Entities (NCE) CDMO Product Offered
11.8.3 Cohance New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Cohance Main Business Overview
11.8.5 Cohance Latest Developments
11.9 Suven Pharma
11.9.1 Suven Pharma Company Information
11.9.2 Suven Pharma New Chemical Entities (NCE) CDMO Product Offered
11.9.3 Suven Pharma New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Suven Pharma Main Business Overview
11.9.5 Suven Pharma Latest Developments
11.10 Syngene
11.10.1 Syngene Company Information
11.10.2 Syngene New Chemical Entities (NCE) CDMO Product Offered
11.10.3 Syngene New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Syngene Main Business Overview
11.10.5 Syngene Latest Developments
11.11 Aarti Pharmalabs Limited (APL)
11.11.1 Aarti Pharmalabs Limited (APL) Company Information
11.11.2 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product Offered
11.11.3 Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Aarti Pharmalabs Limited (APL) Main Business Overview
11.11.5 Aarti Pharmalabs Limited (APL) Latest Developments
11.12 Cerbios-Pharma SA
11.12.1 Cerbios-Pharma SA Company Information
11.12.2 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product Offered
11.12.3 Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Cerbios-Pharma SA Main Business Overview
11.12.5 Cerbios-Pharma SA Latest Developments
11.13 PharmaBlock Sciences Nanjing Inc
11.13.1 PharmaBlock Sciences Nanjing Inc Company Information
11.13.2 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product Offered
11.13.3 PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 PharmaBlock Sciences Nanjing Inc Main Business Overview
11.13.5 PharmaBlock Sciences Nanjing Inc Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. New Chemical Entities (NCE) CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. New Chemical Entities (NCE) CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide NCE
Table 4. Major Players of Oligonucleotide NCE
Table 5. Major Players of Other
Table 6. New Chemical Entities (NCE) CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Table 9. New Chemical Entities (NCE) CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 11. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Table 12. Global New Chemical Entities (NCE) CDMO Revenue by Player (2021-2026) & ($ millions)
Table 13. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player (2021-2026)
Table 14. New Chemical Entities (NCE) CDMO Key Players Head office and Products Offered
Table 15. New Chemical Entities (NCE) CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 19. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Table 20. Global New Chemical Entities (NCE) CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Country (2021-2026)
Table 24. Americas New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Table 26. Americas New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Table 28. APAC New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Table 30. APAC New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Country (2021-2026)
Table 34. Europe New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of New Chemical Entities (NCE) CDMO
Table 40. Key Market Challenges & Risks of New Chemical Entities (NCE) CDMO
Table 41. Key Industry Trends of New Chemical Entities (NCE) CDMO
Table 42. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. KATSURA CHEMICAL CO., LTD Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 47. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product Offered
Table 48. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. KATSURA CHEMICAL CO., LTD Main Business
Table 50. KATSURA CHEMICAL CO., LTD Latest Developments
Table 51. Regis Custom API Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 52. Regis Custom API New Chemical Entities (NCE) CDMO Product Offered
Table 53. Regis Custom API New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Regis Custom API Main Business
Table 55. Regis Custom API Latest Developments
Table 56. Neuland Laboratories Ltd. Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 57. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product Offered
Table 58. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Neuland Laboratories Ltd. Main Business
Table 60. Neuland Laboratories Ltd. Latest Developments
Table 61. Aspen API Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 62. Aspen API New Chemical Entities (NCE) CDMO Product Offered
Table 63. Aspen API New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Aspen API Main Business
Table 65. Aspen API Latest Developments
Table 66. Sai Life Sciences Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 67. Sai Life Sciences New Chemical Entities (NCE) CDMO Product Offered
Table 68. Sai Life Sciences New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sai Life Sciences Main Business
Table 70. Sai Life Sciences Latest Developments
Table 71. Fermion Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 72. Fermion New Chemical Entities (NCE) CDMO Product Offered
Table 73. Fermion New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fermion Main Business
Table 75. Fermion Latest Developments
Table 76. Dipharma Francis Srl (Dipharma) Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 77. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product Offered
Table 78. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Dipharma Francis Srl (Dipharma) Main Business
Table 80. Dipharma Francis Srl (Dipharma) Latest Developments
Table 81. Cohance Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 82. Cohance New Chemical Entities (NCE) CDMO Product Offered
Table 83. Cohance New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Cohance Main Business
Table 85. Cohance Latest Developments
Table 86. Suven Pharma Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 87. Suven Pharma New Chemical Entities (NCE) CDMO Product Offered
Table 88. Suven Pharma New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Suven Pharma Main Business
Table 90. Suven Pharma Latest Developments
Table 91. Syngene Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 92. Syngene New Chemical Entities (NCE) CDMO Product Offered
Table 93. Syngene New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Syngene Main Business
Table 95. Syngene Latest Developments
Table 96. Aarti Pharmalabs Limited (APL) Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 97. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product Offered
Table 98. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Aarti Pharmalabs Limited (APL) Main Business
Table 100. Aarti Pharmalabs Limited (APL) Latest Developments
Table 101. Cerbios-Pharma SA Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 102. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product Offered
Table 103. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Cerbios-Pharma SA Main Business
Table 105. Cerbios-Pharma SA Latest Developments
Table 106. PharmaBlock Sciences Nanjing Inc Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 107. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product Offered
Table 108. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. PharmaBlock Sciences Nanjing Inc Main Business
Table 110. PharmaBlock Sciences Nanjing Inc Latest Developments
Table 1. New Chemical Entities (NCE) CDMO Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. New Chemical Entities (NCE) CDMO Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Peptide NCE
Table 4. Major Players of Oligonucleotide NCE
Table 5. Major Players of Other
Table 6. New Chemical Entities (NCE) CDMO Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 8. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Table 9. New Chemical Entities (NCE) CDMO Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 11. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Table 12. Global New Chemical Entities (NCE) CDMO Revenue by Player (2021-2026) & ($ millions)
Table 13. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player (2021-2026)
Table 14. New Chemical Entities (NCE) CDMO Key Players Head office and Products Offered
Table 15. New Chemical Entities (NCE) CDMO Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 19. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Table 20. Global New Chemical Entities (NCE) CDMO Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Country (2021-2026)
Table 24. Americas New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Table 26. Americas New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Table 28. APAC New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Table 30. APAC New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe New Chemical Entities (NCE) CDMO Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Country (2021-2026)
Table 34. Europe New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of New Chemical Entities (NCE) CDMO
Table 40. Key Market Challenges & Risks of New Chemical Entities (NCE) CDMO
Table 41. Key Industry Trends of New Chemical Entities (NCE) CDMO
Table 42. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global New Chemical Entities (NCE) CDMO Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. KATSURA CHEMICAL CO., LTD Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 47. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Product Offered
Table 48. KATSURA CHEMICAL CO., LTD New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. KATSURA CHEMICAL CO., LTD Main Business
Table 50. KATSURA CHEMICAL CO., LTD Latest Developments
Table 51. Regis Custom API Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 52. Regis Custom API New Chemical Entities (NCE) CDMO Product Offered
Table 53. Regis Custom API New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Regis Custom API Main Business
Table 55. Regis Custom API Latest Developments
Table 56. Neuland Laboratories Ltd. Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 57. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Product Offered
Table 58. Neuland Laboratories Ltd. New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Neuland Laboratories Ltd. Main Business
Table 60. Neuland Laboratories Ltd. Latest Developments
Table 61. Aspen API Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 62. Aspen API New Chemical Entities (NCE) CDMO Product Offered
Table 63. Aspen API New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Aspen API Main Business
Table 65. Aspen API Latest Developments
Table 66. Sai Life Sciences Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 67. Sai Life Sciences New Chemical Entities (NCE) CDMO Product Offered
Table 68. Sai Life Sciences New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. Sai Life Sciences Main Business
Table 70. Sai Life Sciences Latest Developments
Table 71. Fermion Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 72. Fermion New Chemical Entities (NCE) CDMO Product Offered
Table 73. Fermion New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. Fermion Main Business
Table 75. Fermion Latest Developments
Table 76. Dipharma Francis Srl (Dipharma) Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 77. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Product Offered
Table 78. Dipharma Francis Srl (Dipharma) New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Dipharma Francis Srl (Dipharma) Main Business
Table 80. Dipharma Francis Srl (Dipharma) Latest Developments
Table 81. Cohance Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 82. Cohance New Chemical Entities (NCE) CDMO Product Offered
Table 83. Cohance New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Cohance Main Business
Table 85. Cohance Latest Developments
Table 86. Suven Pharma Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 87. Suven Pharma New Chemical Entities (NCE) CDMO Product Offered
Table 88. Suven Pharma New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. Suven Pharma Main Business
Table 90. Suven Pharma Latest Developments
Table 91. Syngene Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 92. Syngene New Chemical Entities (NCE) CDMO Product Offered
Table 93. Syngene New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Syngene Main Business
Table 95. Syngene Latest Developments
Table 96. Aarti Pharmalabs Limited (APL) Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 97. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Product Offered
Table 98. Aarti Pharmalabs Limited (APL) New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Aarti Pharmalabs Limited (APL) Main Business
Table 100. Aarti Pharmalabs Limited (APL) Latest Developments
Table 101. Cerbios-Pharma SA Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 102. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Product Offered
Table 103. Cerbios-Pharma SA New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 104. Cerbios-Pharma SA Main Business
Table 105. Cerbios-Pharma SA Latest Developments
Table 106. PharmaBlock Sciences Nanjing Inc Details, Company Type, New Chemical Entities (NCE) CDMO Area Served and Its Competitors
Table 107. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Product Offered
Table 108. PharmaBlock Sciences Nanjing Inc New Chemical Entities (NCE) CDMO Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 109. PharmaBlock Sciences Nanjing Inc Main Business
Table 110. PharmaBlock Sciences Nanjing Inc Latest Developments
LIST OF FIGURES
Figure 1. New Chemical Entities (NCE) CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. New Chemical Entities (NCE) CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. New Chemical Entities (NCE) CDMO Sales Market Share by Country/Region (2025)
Figure 8. New Chemical Entities (NCE) CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type in 2025
Figure 10. New Chemical Entities (NCE) CDMO in Tumors
Figure 11. Global New Chemical Entities (NCE) CDMO Market: Tumors (2021-2026) & ($ millions)
Figure 12. New Chemical Entities (NCE) CDMO in Cardiovascular Diseases
Figure 13. Global New Chemical Entities (NCE) CDMO Market: Cardiovascular Diseases (2021-2026) & ($ millions)
Figure 14. New Chemical Entities (NCE) CDMO in Other
Figure 15. Global New Chemical Entities (NCE) CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application in 2025
Figure 17. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player in 2025
Figure 18. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas New Chemical Entities (NCE) CDMO Value Market Share by Country in 2025
Figure 24. United States New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Region in 2025
Figure 29. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Country in 2025
Figure 38. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 61. China New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 65. India New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 68. France New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 1. New Chemical Entities (NCE) CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global New Chemical Entities (NCE) CDMO Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. New Chemical Entities (NCE) CDMO Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. New Chemical Entities (NCE) CDMO Sales Market Share by Country/Region (2025)
Figure 8. New Chemical Entities (NCE) CDMO Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Type in 2025
Figure 10. New Chemical Entities (NCE) CDMO in Tumors
Figure 11. Global New Chemical Entities (NCE) CDMO Market: Tumors (2021-2026) & ($ millions)
Figure 12. New Chemical Entities (NCE) CDMO in Cardiovascular Diseases
Figure 13. Global New Chemical Entities (NCE) CDMO Market: Cardiovascular Diseases (2021-2026) & ($ millions)
Figure 14. New Chemical Entities (NCE) CDMO in Other
Figure 15. Global New Chemical Entities (NCE) CDMO Market: Other (2021-2026) & ($ millions)
Figure 16. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Application in 2025
Figure 17. Global New Chemical Entities (NCE) CDMO Revenue Market Share by Player in 2025
Figure 18. Global New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Figure 19. Americas New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 20. APAC New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 21. Europe New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size 2021-2026 ($ millions)
Figure 23. Americas New Chemical Entities (NCE) CDMO Value Market Share by Country in 2025
Figure 24. United States New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Region in 2025
Figure 29. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 30. APAC New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 31. China New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 35. India New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Country in 2025
Figure 38. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 39. Europe New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 40. Germany New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 41. France New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 42. UK New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size Market Share by Application (2021-2026)
Figure 48. Egypt New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries New Chemical Entities (NCE) CDMO Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 54. APAC New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 55. Europe New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 57. United States New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 58. Canada New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 59. Mexico New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 60. Brazil New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 61. China New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 62. Japan New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 63. Korea New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 65. India New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 66. Australia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 67. Germany New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 68. France New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 69. UK New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 70. Italy New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 71. Russia New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 72. Egypt New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 73. South Africa New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 74. Israel New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 75. Turkey New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
Figure 76. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global New Chemical Entities (NCE) CDMO Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries New Chemical Entities (NCE) CDMO Market Size 2027-2032 ($ millions)
